254
Views
15
CrossRef citations to date
0
Altmetric
Articles

Serum concentration of renin-angiotensin system components in association with ACE I/D polymorphism among hypertensive subjects in response to ACE inhibitor therapy

, &
Pages 662-669 | Received 07 Aug 2018, Accepted 23 Sep 2018, Published online: 11 Oct 2018

References

  • O’Donnell CJ, Elosua R. Cardiovascular risk factors. Insights from framingham heart study. Rev Esp Cardiol. 2008;61(3):299–310. doi:10.1016/S1885-5857(08)60118-8.
  • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, et al. Joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. National heart, lung, and blood institute; national high blood pressure education program coordinating committee. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206–52. doi:10.1161/01.HYP.0000107251.49515.c2.
  • Yim HE, Yoo KH. Renin-Angiotensin system - considerations for hypertension and kidney. Electrolyte Blood Press. 2008;6(1):42–50. doi:10.5049/EBP.2008.6.1.42.
  • Sparks MA, Crowley SD, Gurley SB, Mirotsou M, Coffman TM. Classical renin-angiotensin system in kidney physiology. Compr Physiol. 2014;4(3):1201–28. doi:10.1002/cphy.c130040.
  • Urata H, Kinoshita A, Misono KS, Bumpus FM, Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem. 1990;265(36):22348–2257.
  • Lorenz JN. Chymase: the other ACE? Am J Physiol Ren Physiol. 2010;298:F35–F36. doi:10.1152/ajprenal.00641.2009.
  • Dell’Italia LJ, Collawn JF, Ferrario CM. Multifunctional role of chymase in acute and chronic tissue injury and remodeling. Circ Res. 2018;122(2):319–36. doi:10.1161/CIRCRESAHA.117.310978.
  • Company C, Piqueras L, Naim Abu Nabah Y, Escudero P, Blanes JI, Jose PJ, Morcillo EJ, Sanz MJ. Contributions of ACE and mast cell chymase to endogenous angiotensin II generation and leucocyte recruitment in vivo. Cardiovasc Res. 2011;92(1):48–56. doi:10.1093/cvr/cvr147.
  • Li S, Wang Z, Yang X, Hu B, Huang Y, Fan S. Association between circulating angiotensin-converting enzyme 2 and cardiac remodeling in hypertensive patients. Peptides. 2017;90:63–68. doi:10.1016/j.peptides.2017.02.007.
  • Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86(4):1343–46. doi:10.1172/JCI114844.
  • Sagnella GA, Rothwell MJ, Onipinla AK, Wicks PD, Cook DG, Cappuccio FP. A population study of ethnic variations in the angiotensin-converting enzyme I/D polymorphism: relationships with gender, hypertension and impaired glucose metabolism. J Hypertens. 1999;17(5):657–64.
  • Bedir A, Arik N, Adam B, Kilinç K, Gümüş T, Güner E. Angiotensin converting enzyme gene polymorphism and activity in Turkish patients withessential hypertension. Am J Hypertens. 1999;12(10 Pt 1):1038–43.
  • Mondry A, Loh M, Liu P, Zhu AL, Nagel M. Polymorphisms of the insertion/deletion ACE and M235T AGT genes and hypertension: surprisingnew findings and meta-analysis of data. BMC Nephrol. 2005;6:1. doi:10.1186/1471-2369-6-1.
  • Polupanov A, Halmatov A, Pak O, Romanova T, Kim E, Cheskidova N, Aldashev A, Dzhumagulova A. The I/D polymorphism of the angiotensin converting enzyme gene as a risk factor for ischemic stroke in patients with essential hypertension in Kyrgyz population. Türk Kardiyol Dern Arfl - Arch Turk Soc Cardiol. 2007;35(6):347–53.
  • Krishnan R, Sekar D, Karunanithy S, Subramanium S. Association of angiotensin converting enzyme gene insertion/deletion polymorphism with essential hypertension in south Indian population individual’s genetic milieu. Genes Dis. 2016;3(2):159–63. doi:10.1016/j.gendis.2016.03.001.
  • Singh M, Singh AK, Singh S, Pandey P, Chandra S, Gambhir IS. Angiotensin-converting enzyme gene I/D polymorphism increases the susceptibility to hypertension and additive diseases: A study on North Indian patients. Clin Exp Hypertens. 2016;38(3):305–11. doi:10.3109/10641963.2015.1107085.
  • Sun F, He N, Zhang K, Wu N, Zhao J, Qiu C. Association of ACE gene A2350G and I/D polymorphisms with essential hypertension in the northernmost province of China. Clin Exp Hypertens. 2018;40(1):32–38. doi:10.1080/10641963.2017.1291659.
  • Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the european society of hypertension (ESH) and of the european society of cardiology (ESC). Eur Heart J. 2013;34(28):2159–219. doi:10.1093/eurheartj/eht151.
  • Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 1992;20(6):1433. doi:10.1093/nar/20.6.1433-a.
  • Shanmugam V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Methods Appl. 1993;3:120–21. doi:10.1101/gr.3.2.120.
  • Santos RA, Ferreira AJ, Simões E, Silva AC. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Exp Physiol. 2008;93(5):519–27. doi:10.1113/expphysiol.2008.042002.
  • Patel SK, Velkoska E, Freeman M, Wai B, Lancefield TF, Burrell LM. From gene to protein—experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension. Fron Physiol. 2014;5:227. doi:10.3389/fphys.2014.00227.
  • Maranon R, Reckelhoff JF. Sex and gender differences in control of blood pressure. Clin Sci (London, England: 1979). 2013;125(7):311–18. doi:10.1042/CS20130140.
  • Úri K, Fagyas M, Mányiné Siket I, Kertész A, Csanádi Z, Sándorfi G, Clemens M, Fedor R, Papp Z, Édes I, et al. New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure. PLoS One. 2014;9(4):e87845. doi:10.1371/journal.pone.0087845.eCollection2014.
  • Hristova M, Penev M, Stanilova S, Miteva L. Preliminary study of the serum chymase levels in patients with arterial hypertension. TJS. 2015;13(Suppl. 2):160–65. doi:10.15547/tjs.2015.s.02.034.
  • Bot I, van Berkel TJ, Biessen EA. Mast cells: pivotal players in cardiovascular diseases. Curr Cardiol Rev. 2008;4(3):170–78. doi:10.2174/157340308785160624.
  • Miyazaki M, Takai S. Tissue angiotensin II generating system by angiotensin- converting enzyme and chymase. J Pharmacol Sci. 2006;100(5):391–97. doi:10.1254/jphs.CPJ06008X.
  • Okamura K, Okuda T, Shirai K, Urata H. Positive correlation between blood pressure or heart rate and chymase-dependent angiotensin II-forming activity in circulating mononuclear leukocytes measured by new ELISA. Clin Exp Hypertens. 2018;40(2):112–17. doi:10.1080/10641963.2017.1339071.
  • Wei CC, Tian B, Perry G, Meng QC, Chen YF, Oparil S, Dell’Italia LJ. Differential ANG II generation in plasma and tissue of mice with decreased expression of the ACE gene. Am J Physiol Heart Circ Physiol. 2002;282(6):H2254–H2258. doi:10.1152/ajpheart.00191.2001.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.